Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/14796
Title: Screening, isolation, taxonomy and fermentation of an antibiotic producer <i style="mso-bidi-font-style:normal">Streptomyces xinghaiensis</i> from soil capable of acting against linezolid resistant strains
Authors: Kumar, Konda Shravan
Anuradha, Sriramoju
Sarma, Gadepalli Rama
Venkateshwarlu, Yenamandra
Kishan, Veerabrahma
Keywords: Antibiotic
Linezolid resistance
Reductiomycin
<i style="mso-bidi-font-style:normal"><span style="font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-fareast-font-family: "Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:EN-US; mso-bidi-language:AR-SA" lang="EN-US">Streptomyces xinghaiensis</span></i>
Issue Date: Oct-2012
Publisher: NISCAIR-CSIR, India
Abstract: Linezolid resistant cultures are emerging in hospitals. In the present study 3 soil <i style="mso-bidi-font-style:normal">actinomycetes </i>were isolated in a screening programme having potential to produce antibiotic against linezolid resistant cases. One culture was coded as RK-46 and further studied. The micromorphology, biochemical tests and 16S ribosomal DNA gene sequence analysis were conducted to know the identity of the culture and was found as a strain of <i style="mso-bidi-font-style:normal">Streptomyces xinghaiensis</i>. The culture produced antibiotic active against five clinical resistant strains. The antibiotic production was tested by cultivating in eleven different media. The fermentation profile was studied in YEME medium supplemented with calcium carbonate. The maximum activity was noticed at 72 h. Antibiotic activity was extracted into ethyl acetate and was subjected to activity guided purification by column chromatography, TLC and HPLC methods. The pure compound was eluted with retention time of 6.8 min and subjected to <sup>1</sup>H, <sup>13</sup>C NMR and Mass spectral analysis. The acquired data was compared with that in natural products data base, and was found to be a known antibiotic, reductiomycin. The purified compound showed activity against 5 linezolid resistant cultures and on <i style="mso-bidi-font-style:normal">Mycobacterium tuberculosis. </i>This compound is also showing mild anti cancer activity and is biologically permeable as per Lipinksi’s rule.
Description: 718-728
URI: http://hdl.handle.net/123456789/14796
ISSN: 0975-1009 (Online); 0019-5189 (Print)
Appears in Collections:IJEB Vol.50(10) [October 2012]

Files in This Item:
File Description SizeFormat 
IJEB 50(10) 718-728.pdf158.43 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.